deltatrials
Completed PHASE2/PHASE3 NCT00148356

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System Compared to the TAXUS™ Express2 Paclitaxel-Eluting Coronary Stent System in de Novo Coronary Artery Lesions

Sponsor: Abbott Medical Devices

Conditions Coronary Artery Disease Coronary Disease Coronary Restenosis
Interventions TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System ZoMaxx™ Drug-Eluting Coronary Stent System
Updated 8 times since 2017 Last updated: Mar 31, 2011 Started: Sep 30, 2004 Primary completion: May 31, 2006 Completion: Oct 31, 2010

This PHASE2/PHASE3 trial investigates Coronary Artery Disease and Coronary Disease and is currently completed. Abbott Medical Devices leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Dec 2018 [monthly]

    Completed PHASE2_PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott Medical Devices
Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalst, Belgium, Aarhus, Denmark, Antwerp, Belgium, Auckland, New Zealand, Bad Krozingen, Germany, Carnaxide, Portugal, Copenhagen, Denmark, Dortmund, Germany, Dunedin, New Zealand, Essen, Germany and 17 more location s